Provided by Tiger Trade Technology Pte. Ltd.

RenovoRx Inc

1.32
0.0000
Post-market: 1.31-0.0100-0.76%19:30 EDT
Volume:233.27K
Turnover:301.54K
Market Cap:59.47M
PE:-4.26
High:1.33
Open:1.30
Low:1.25
Close:1.32
52wk High:1.51
52wk Low:0.7006
Shares:45.05M
Float Shares:39.17M
Volume Ratio:0.32
T/O Rate:0.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3096
EPS(LYR):-0.3161
ROE:-125.23%
ROA:-64.90%
PB:6.62
PE(LYR):-4.18

Loading ...

RenovoRx Inc expected to post a loss of 8 cents a share - Earnings Preview

Reuters
·
May 13

RenovoRx forecasts 2026 revenue of $3 million-$4 million

Reuters
·
May 05

RenovoRx announces annual shareholder meeting

Reuters
·
May 01

Analysts Offer Insights on Healthcare Companies: RenovoRx (RNXT) and Protara Therapeutics (TARA)

TIPRANKS
·
Apr 29

RenovoRx Announces Pharmacokinetic and Pharmacodynamic Data Abstract Supporting the TAMP™ Therapy Platform Accepted for Presentation at the 2026 ASCO Annual Meeting

GlobeNewswire
·
Apr 23

RenovoRx files to sell 8.44M shares of common stock for holders

TIPRANKS
·
Apr 17

RenovoRx says TAMP study shows reduced tumor activity in pancreatic cancer patients

Reuters
·
Apr 14

RenovoRx Price Target Maintained With a $3.00/Share by HC Wainwright & Co.

Dow Jones
·
Apr 09

RenovoRx secures Japanese patent allowance for targeted drug-delivery

TIPRANKS
·
Apr 08

RenovoRx wins Japan patent allowance for RenovoCath drug-delivery device

Reuters
·
Apr 08

RenovoRx Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026

GlobeNewswire
·
Apr 02

Analysts Offer Insights on Healthcare Companies: AbSci (ABSI) and RenovoRx (RNXT)

TIPRANKS
·
Apr 01

RenovoRx Q4 EPS $(0.08), Inline, Sales $238.000K Miss $419.750K Estimate

Benzinga Earnings
·
Mar 31

RenovoRx net loss widens to $11 million in FY25; revenue climbs to $1.1 million

Reuters
·
Mar 31

BRIEF-RenovoRx FY Net Income USD -11.168 Million

Reuters
·
Mar 31

RenovoRx FY Basic EPS USD -0.32

THOMSON REUTERS
·
Mar 31

RenovoRx Reports Full Year 2025 Financial Results and Provides Business Update

GlobeNewswire
·
Mar 31

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 30

RenovoRx Inc expected to post a loss of 8 cents a share - Earnings Preview

Reuters
·
Mar 28

RenovoRx Inc - Appoints Ramtin Agah as Executive Chairman Effective February 27, 2026 - SEC Filing

THOMSON REUTERS
·
Mar 27